[Skip to Content]
[Skip to Content Landing]
Views 378
Citations 0
Clinical Trials Update
October NaN, 2013

Depression Remains Stable in Smokers Taking Varenicline to Quit

JAMA. 2013;310(16):1665. doi:10.1001/jama.2013.281200

Varenicline helped smokers with stable major depression quit smoking without exacerbating depression or anxiety, reported researchers of a phase 4 trial conducted in 8 countries (Anthenelli RM et al. Ann Intern Med. 2013;159[6]:390-400). The trial was funded by Pfizer.

Some previous trials assessing varenicline for smoking cessation excluded participants with psychiatric diseases. Depression increases nicotine dependence and severity of nicotine withdrawal symptoms, and about half of smokers who want to quit have a history of depression.

First Page Preview View Large
First page PDF preview
First page PDF preview